Multiple roles of charged amino acids in cytoplasmic loop 7 for expression and function of the multidrug and organic anion transporter MRP1 (ABCC1)

Molecular Pharmacology

Volumn 75, Issue 2, 2009, Pages 397-406

  Conseil, Gwenaëlle ^a   Rothnie, Alice J ^b   Deeley, Roger G ^a   Cole, Susan P C ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MULTIDRUG RESISTANCE PROTEIN 1;

AMINO ACID SEQUENCE; ARTICLE; CELL MEMBRANE TRANSPORT; CELL STRAIN HEK293; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOLECULAR MODEL; NUCLEOTIDE BINDING SITE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SECONDARY STRUCTURE; SEQUENCE ALIGNMENT; SITE DIRECTED MUTAGENESIS; STRUCTURE ACTIVITY RELATION; TRANSPORT KINETICS;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; AMINO ACIDS; ANIMALS; AZIDES; BIOLOGICAL TRANSPORT; CELLS, CULTURED; GENE EXPRESSION; HUMANS; ISOTOPE LABELING; MICE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; ORGANIC ANION TRANSPORTERS; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ALIGNMENT;

EID: 59449105325     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.108.052860     Document Type: Article

References (46)

1. Bakos E, Evers R, Szakács G, Tusnády GE, Welker E, Szabó K, de Haas M, van Deemter L, Borst P, Váradi A, and Sarkadi B (1998) Functional multidrug resistance protein (MRP1) lacking the N-terminal transmembrane domain. J Biol Chem 273:32167-32175.
2. Bakos E, Evers R, Calenda G, Tusnády GE, SzakácsG, Váradi A, and Sarkadi B (2000) Characterization of the amino-terminal regions in the human multidrug resistance protein (MRP1). J Cell Sci 113:4451-4461.
3. Conseil G, Deeley RG, and Cole SPC (2005) Role of two adjacent cytoplasmic tyrosine residues in MRP1 (ABCC1) transport activity and sensitivity to sulfonylureas. Biochem Pharmacol 69:451-461.
4. Conseil G, Deeley RG, and Cole SPC (2006) Functional importance of three basic residues clustered at the cytosolic interface of transmembrane helix 15 in the multidrug and organic anion transporter MRP1 (ABCC1). J Biol Chem 281:43-50.
5. Cotten JF, Ostedgaard LS, Carson MR, and Welsh MJ (1996) Effect of cystic fibrosis-associated mutations in the fourth intracellular loop of cystic fibrosis transmem-brane conductance regulator. JBiol Chem 271:21279-21284.
6. Cremonesi L, Cainarca S, Rossi A, Padoan R, and Ferrari M (1996) Detection ofa de novo R1066H mutation in an Italian patient affected by cystic fibrosis. Hum Genet 98:119 -121.
7. Cui Y, König J, Buchholz JK, Spring H, Leier I, and Keppler D (1999) Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. Mol Pharmacol 55:929-937.
8. Cui L, Hou YX, Riordan JR, and Chang XB (2001) Mutations of the Walker B motif in the first nucleotide binding domain of multidrug resistance protein MRP1 prevent conformational maturation. Arch Biochem Biophys 392:153-161.
9. Dawson RJ and Locher KP (2006) Structure of a bacterial multidrug ABC transporter. Nature 443:180-185.
10. Dawson RJ and Locher KP (2007) Structure of the multidrug ABC transporter Sav1866 from Staphylococcus aureus in complex with AMP-PNP. FEBS Lett 581:935-938.
11. Deeley RG, Westlake C, and Cole SPC (2006) Transmembrane transport ofendo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. Physiol Rev 86:849 -899.
12. DeGorter MK, Conseil G, Deeley RG, Campbell RL, and Cole SP (2008) Molecular modeling of the human multidrug resistance protein 1 (MRP1/ABCC1). Biochem Biophys Res Commun 365:29 -34.
13. Du K, Sharma M, and Lukacs GL (2005) The AF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR. Nat Struct Mol Biol 12:17-25.
14. Falcón-Pérez JM, Mazón MJ, Molano J, and Eraso P (1999) Functional domain analysis of the yeast ABC transporter Ycf1p by site-directed mutagenesis. J Biol Chem 274:23584-23590.
15. Fanen P, Ghanem N, Vidaud M, Besmond C, Martin J, Costes B, Plassa F, and Goossens M (1992) Molecular characterization of cystic fibrosis: 16 novel mutations identified by analysis of the whole cystic fibrosis conductance transmem- brane regulator (CFTR) coding regions and splice site junctions. Genomics 13:770-776.
16. Fanen P, Labarthe R, Garnier F, Benharouga M, Goossens M, and Edelman A (1997) Cystic fibrosis phenotype associated with pancreatic insufficiency does not always reflect the cAMP-dependent chloride conductive pathway defect. Analysis of C225R-CFTR and R1066C-CFTR. J Biol Chem 272:30563- 30566.
17. Ferec C, Audrezet MP, Mercier B, Guillermit H, Moullier P, Quere I, and Verlingue C (1992) Detection of over 98% cystic fibrosis mutations in a Celtic population. Nat Genet 1:188-191.
18. 4. J Biol Chem 273:10733-10740.
19. Haimeur A, Deeley RG, and Cole SPC (2002) Charged amino acids in the sixth transmembrane helixofmultidrugresistance protein 1 (MRP1/ABCC1) are critical determinants of transport activity. J Biol Chem 277:41326-41333.
20. Haimeur A, Conseil G, Deeley RG, and Cole SPC (2004) Mutations ofcharged amino acids in or near the transmembrane helices of the second membrane spanning domain differentially affect the substrate specificity and transport activity of the multidrug resistance protein MRP1 (ABCC1). Mol Pharmacol 65:1375-1385.
21. Hipfner DR, Almquist KC, Stride BD, Deeley RG, and Cole SPC (1996) Location of a protease-hypersensitive region in the multidrug resistance protein (MRP) by mapping of the epitope of MRP-specific monoclonal antibody QCRL-1. Cancer Res 56:3307-3314.
22. Hipfner DR, Almquist KC, Leslie EM, Gerlach JH, Grant CE, Deeley RG, and Cole SPC (1997) Membrane topology of the multidrug resistance protein (MRP). A study of glycosylation-site mutants reveals an extracytosolic terminus. J Biol Chem 272:23623-23630.
23. Ito K, Olsen SL, Qiu W, Deeley RG, and Cole SPC (2001) Mutation of a single conserved tryptophan in multidrug resistance protein 1 (MRP1/ABCC1) results in loss of drug resistance and selective loss of organic anion transport. J Biol Chem 276:15616-15624.
24. 2-terminal region of the multidrug resistance protein, MRP1 (ABCC1): effects on protein expression, membrane localization, and transport function. Biochim Biophys Acta 1615:103-114.
25. Kast C and Gros P (1998) Epitope insertion favors a six transmembrane domain model for the carboxy-terminal portion of the multidrug resistance-associated protein. Biochemistry 37:2305-2313.
26. Koike K, Conseil G, Leslie EM, Deeley RG, and Cole SP (2004) Identification of proline residues in the core cytoplasmic and transmembrane regions of multidrug resistance protein 1 (MRP1/ABCC1) important for transport function, substrate specificity, and nucleotide interactions. J Biol Chem 279:12325-12336.
27. Le Saux O, Urban Z, Tschuch C, Csiszar K, Bacchelli B, Quaglino D, Pasquali-Ronchetti I, Pope FM, Richards A, Terry S, et al. (2000) Mutations in a gene encoding an ABC transporter cause Pseudoxanothoma elasticum. Nat Genet 25: 223-227.
28. 2-proximal region of the human multidrug resistance protein 1 (MRP1/ABCC1). Biochemistry 42:5214-5224.
29. Leslie EM, Deeley RG, and Cole SPC (2003b) Bioflavonoid stimulation ofglutathione transport by the 190-kDa multidrug resistance protein 1 (MRP1). Drug Metab Dispos 31:11-15.
30. Leslie EM, Deeley RG, and Cole SPC (2005) Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2 and BCRP (ABCG2) in tissue defense. Toxicol Appl Pharmacol 204:216-237.
31. Letourneau IJ, Deeley RG, and Cole SPC (2005) Functional characterization of non-synonymous single nucleotide polymorphisms in the gene encoding human multidrug resistance protein 1 (MRP1/ABCC1). Pharmacogenet Genomics 15:647-657.
32. Letourneau IJ, Nakajima A, Deeley RG, and Cole SPC (2008) Role of proline 1150 in functional interactions between the membrane spanning domains and nucleotide binding domains ofthe MRP1 (ABCC1) transporter. Biochem Pharmacol 75:1659-1669.
33. Locher KP, Lee AT, and Rees DC (2002) The E. coli BtuCD structure: a framework for ABC transporters architecture and mechanism. Science 296:1091-1098.
34. 4 and chemotherapeutic agents in membrane vesicles: demonstration ofglutathione- dependent vincristine transport. J Biol Chem 271:9675-9682.
35. Mercier B, Lissens W, Novelli G, Kalaydjieva L, De Arce M, Kapranov N, Klain NC, Lenoir G, Chauveau P, Lenaerts C, et al. (1993) Identification of eight novel mutations in a collaborative analysis of a part of the second transmembrane domain of the CFTR gene. Genomics 16:296-297.
36. Mendoza JL and Thomas PJ (2007) Building an understanding of cystic fibrosis on the foundation of ABC transporter structures. J Bioenerg Biomembr 39:499 -505.
37. Müller M, Yong M, Peng XH, Petre B, Arora S, and Ambudkar SV (2002) Evidence for the role of glycosylation in accessibility of the extracellular domains of human MRP1 (ABCC1). Biochemistry 41:10123-10132.
38. Payen LF, Gao M, Westlake CJ, Cole SP, and Deeley RG (2003) Role ofcarboxylate residues adjacent to the conserved core Walker B motifs in the catalytic cycle of multidrug resistance protein 1 (ABCC1). JBiol Chem 278:38537-38547.
39. Ren XQ, Furukawa T, Yamamoto M, Aoki S, Kobayashi M, Nakagawa M, and Akiyama S (2006) A functional role of intracellular loops of human multidrug resistance protein. J Biochem (Tokyo) 140:313-318.
40. Ringpfeil F, Lebwohl MG, Christiano AM, and Uitto J (2000) Pseudoxanthomaelasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter. Proc Natl Acad Sci U S A 97:6001-6006.
41. Sauna ZE and Ambudkar SV (2001) Characterization of the catalytic cycle of ATP hydrolysis by human P-glycoprotein. The two ATP hydrolysis events in a single catalytic cycle are kinetically similar but affect different functional outcomes. J Biol Chem 276:11653-11661.
42. Seibert FS, Linsdell P, Loo TW, Hanrahan JW, Clarke DM, and Riordan JR (1996)Disease-associated mutations in the fourth cytoplasmic loop of cystic fibrosis transmembrane conductance regulator compromise biosynthetic processing and chloride channel activity. J Biol Chem 271:15139-15145.
43. Situ D, Haimeur A, Conseil G, Sparks KE, Zhang D, Deeley RG, and Cole SPC (2004) Mutational analysis of ionizable residues proximal to the cytoplasmic interface of membrane spanning domain 3 of the multidrug resistance protein, MRP1 (ABCC1): glutamate 1204 is important for both the expression and catalytic activity of the transporter. J Biol Chem 279:38871-38880.
44. Westlake CJ, Qian YM, Gao M, Vasa M, Cole SP, and Deeley RG (2003) Identification of the structural and functional boundaries of the multidrug resistance protein 1 cytoplasmic loop 3. Biochemistry 42:14099 -14113.
45. Xie J, Drumm ML, Ma J, and Davis PB (1995) Intracellular loop between transmem-brane segments IV and V of cystic fibrosis transmembrane conductance regulator is involved in regulation of chloride channel conductance state. J Biol Chem 270:28084-28091.
46. Yang R, Scavetta R, and Chang XB (2008) The hydroxyl group ofS685 in Walker A motif and the carboxyl group of D792 in Walker B motifofNBD1 play a crucial role for multidrug resistance protein folding and function. Biochim Biophys Acta 1778: 454-465.